Welcome to our dedicated page for Globe Life SEC filings (Ticker: GL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Globe Life Inc. (NYSE: GL) filings with the U.S. Securities and Exchange Commission, along with AI-generated explanations to help interpret key disclosures. Globe Life is an insurance holding company focused on life and supplemental health insurance, annuities and related investment activities, and its SEC filings offer detailed insight into these operations.
Investors can review current reports on Form 8-K, where Globe Life reports material events such as quarterly earnings releases, changes to executive retirement or compensation plans and significant financing arrangements. For example, recent 8-K filings describe the company’s second and third quarter financial results, an amendment to the Supplemental Executive Retirement Plan and the creation of a pre-capitalized trust securities (P-CAP) program that provides contingent liquidity through senior notes.
Filings also document corporate governance and executive arrangements, including early retirement reduction factors and vesting rules under the SERP in connection with change-of-control protection periods. These disclosures help clarify how Globe Life structures retirement benefits and severance protections for certain executives.
Through this page, users can track debt and capital structure–related disclosures, such as facility agreements, trust arrangements and obligations tied to senior notes and pre-capitalized trust securities. These items illustrate how Globe Life manages liquidity and long-term financing in support of its insurance and investment activities.
The platform supplements raw filings with AI-powered summaries that highlight important sections, explain technical terms and distinguish between GAAP and non-GAAP measures when referenced in attached earnings materials. Real-time updates from EDGAR ensure that new 8-Ks and other forms appear promptly, while structured data views make it easier to locate information related to executive plans, financing arrangements and reported results.
GLOBE LIFE INC. senior vice president and chief accounting officer Michael Shane Henrie reported a Form 4 transaction involving company common stock. On February 22, 2026, 174 shares were disposed of at $144.39 per share in a tax-withholding disposition related to equity compensation. After this, his directly held common stock totaled 2,876.0833 shares, which the footnote explains includes 10.0833 dividend-equivalent restricted stock units acquired on restricted stock units in 2025 and 2026. He also reports indirect ownership of 157.19 shares held through a 401(k) plan.
GLOBE LIFE INC. reported that Co-Chairman & CEO Frank M. Svoboda had a tax-withholding disposition of 1,327 shares of common stock on February 22, 2026 at $144.3900 per share, coded as a payment of tax liability by delivering securities. After this transaction, he held 34,571.4648 shares directly, which include 30.4648 dividend equivalent restricted stock units tied to prior awards. He also reported indirect holdings of 108,473.0000 shares through a Family Trust, 26,425.0000 shares through a Spouse's Irrevocable Trust, and 1,951.1300 shares through a 401(k) Plan.
Globe Life Inc. director and Co-Chairman & CEO James Matthew Darden reported a tax-related share disposition. On February 22, 2026, 1,343 shares of common stock were disposed of at $144.39 per share to satisfy tax withholding obligations. After this transaction, he held 48,529.4598 shares directly and 4,185.585 shares indirectly through a 401(k) plan, which include a small number of dividend equivalent restricted stock units.
GLOBE LIFE INC. Co-Chairman & CEO Frank M. Svoboda reported exercising employee stock options for 12,500 shares on 2026-02-17, acquiring common stock at an exercise price of $82.5600 per share. This increased his directly held common stock before subsequent sales.
On the same date, he sold a total of 12,500 common shares in open-market transactions, in three blocks of 3,595, 6,451 and 2,454 shares at average prices of $143.9489, $144.9556 and $145.5165 per share, leaving 35,868 shares held directly. He also reports indirect ownership of 108,473 shares through a Family Trust, 26,425 shares through a Spouse's Irrevocable Trust, and 1,951.130 shares through a 401(k) Plan.
A holder of Globe Life Inc. common stock filed a notice of proposed sale of 12,500 shares under Rule 144. The shares are to be sold through Apex Clearing on the NYSE, with an aggregate market value listed as 1,801,250 and total shares outstanding of 78,580,771.
The seller acquired these 12,500 shares on the same date through a stock option exercise, with the consideration described as proceeds of the option exercise. By signing the notice, the seller represents they are not aware of any undisclosed material adverse information about Globe Life’s current or prospective operations.
Globe Life Inc. executive Jennifer A. Haworth, EVP & Chief Marketing Officer, exercised an employee stock option for 10,000 shares of common stock at an exercise price of $50.64 per share on February 12, 2026. She then sold 10,000 shares of Globe Life common stock in multiple open-market transactions the same day at prices ranging from $141.595 to $144.075 per share. Following these transactions, she directly owned 17,479 shares of common stock and indirectly held 1,938.443 shares through a Thrift/401(k) Plan trust.
Globe Life Inc. has an affiliated holder filing a notice to sell 10,000 shares of its common stock under Rule 144. The shares are to be sold through APEX Clearing on the NYSE, with an aggregate market value of 1,471,000 and 78,580,771 shares outstanding. The approximate sale date given is 02/12/2026. The seller acquired the 10,000 shares on 02/09/2026 through a stock option exercise from Globe Life Inc., with payment dated 02/12/2026.
Globe Life Inc. executive vice president and chief financial officer Thomas P. Kalmbach reported acquiring 7,537 shares of Globe Life common stock on February 26, 2025 at a reported price of $0, leaving him with 25,780.945 shares beneficially owned directly after the transaction.
The amended filing states this total includes 17.136 shares acquired through the company’s dividend reinvestment plan since the last report and clarifies that the amendment was made to correct the beneficial ownership amount, which also affects one subsequent filing.
Globe Life Inc. director Mark A. Blinn reported an indirect sale of common stock through a trust. On 02/06/2026, the trust sold 1,750 Globe Life shares at $147.91 per share. After the sale, Blinn held 1,373 shares directly and 3,372 shares indirectly through the trust.
Globe Life Inc. director amends prior insider trade report to clarify ownership. The amended Form 4 shows that on January 6, 2025, a trust associated with the director sold 3,000 shares of Globe Life common stock at $113.235 per share.
After the sale, the director holds 1,604 shares directly and 3,518 shares indirectly through the trust. The amendment corrects the earlier filing to state that the transaction was executed from the reporting person's trust account rather than from a direct personal holding.